Oncogene mutations as intermediate markers.

Abstract excerpt

Tumors arise through a series of genetic changes which include activation of protoocogenes and inactivation of tumor suppressor genes. It is now possible to identify rare cells containing genetic mutations in an excess background of normal cells. Theoretically, the identification of a clonal population of cells sharing an early genetic marker for malignant transformation would lead to valuable intermediate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticarcinogenic Agents
• Share to Biomarkers, Tumor
• Share to Mutation